This decommissioned ERA site remains active temporarily to support our final migration steps to https://ualberta.scholaris.ca, ERA's new home. All new collections and items, including Spring 2025 theses, are at that site. For assistance, please contact erahelp@ualberta.ca.
Search
Skip to Search Results- 1Adjuvant chemotherapy
- 1Cancer Epidemiology/ Cancer Biostatistics
- 1Colon cancer
- 1Comparative effectiveness
- 1Congenital heart disease
- 1Health Disparities
-
Disparity in Forgoing Medical Care Across Race/Ethnicity Groups Among Long-term Adult Survivors of Childhood Cancer
DownloadSpring 2020
Background: Foregoing medical care is of concern among adult childhood cancer survivors because they are at high-risk for developing a variety of chronic health conditions due to exposures to cancer treatment in childhood. Objectives: I assessed disparity across race/ethnicity groups in access...
-
Fall 2014
The prevalence of congenital heart disease (CHD) is rising, particularly among adults. The rise is particularly prominent for CHD with complex lesions. The impact of these changes on the healthcare system/resource is not known. The first part of this thesis used the hospital discharge abstract...
-
Population-based evaluation of disparities in survival of lung cancer patients in Alberta, Canada
DownloadFall 2014
Lung cancer patients of Alberta have lower relative survival compared to their counterparts in Manitoba, British Columbia and Ontario. We conducted two population-based cancer mortality studies to explore the underlying reasons. The first study assessed disparities in mortality across five...
-
Reasons for not receiving standard of care treatment and effectiveness of capecitabine in stage III colon cancer patients in Alberta
DownloadFall 2011
Adjuvant chemotherapy is the standard of care for stage-III colon cancer. Despite this, large proportions of patients do not receive it; the oncologist may not recommend it or the patient may refuse it. We aimed to identify the physicians’ and patients’ reasons for making treatment decisions. We...